Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Use of a Valved-Conduit for Exclusion of the Infected Portion in the Prosthetic Pulmonary Valve Endocarditis

  • Jung, Joonho (Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine) ;
  • Hong, You Sun (Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine) ;
  • Lee, Cheol Joo (Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine) ;
  • Lim, Sang-Hyun (Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine) ;
  • Choi, Ho (Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine) ;
  • Park, Soo-Jin (Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine)
  • Received : 2012.09.24
  • Accepted : 2012.10.22
  • Published : 2013.06.05
Download PDF
⟨ Previous Next ⟩

Abstract

A 51-year-old male was admitted to the hospital with complaints of fever and hemoptysis. After evaluation of the fever focus, he was diagnosed with pulmonary valve infective endocarditis. Thus pulmonary valve replacement and antibiotics therapy were performed and discharged. He was brought to the emergency unit presenting with a high fever (> $39^{\circ}C$) and general weakness 6 months after the initial operation. The echocardiography revealed prosthetic pulmonary valve endocarditis. Therefore, redo-pulmonary valve replacement using valved conduit was performed in the Rastelli fashion because of the risk of pulmonary arterial wall injury and recurrent endocarditis from the remnant inflammatory tissue. We report here on the successful surgical treatment of prosthetic pulmonary valve endocarditis with an alternative surgical method.

Keywords

References

  1. Arvay A, Lengyel M. Incidence and risk factors of prosthetic valve endocarditis. Eur J Cardiothorac Surg 1988;2: 340-6. https://doi.org/10.1016/1010-7940(88)90010-3
  2. Hill EE, Herregods MC, Vanderschueren S, Claus P, Peetermans WE, Herijgers P. Management of prosthetic valve infective endocarditis. Am J Cardiol 2008;101:1174-8. https://doi.org/10.1016/j.amjcard.2007.12.015
  3. Horstkotte D, Follath F, Gutschik E, et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis: executive summary. Rev Esp Cardiol 2004;57:952-62. https://doi.org/10.1016/S0300-8932(04)77224-3
  4. Mouly S, Ruimy R, Launay O, et al. The changing clinical aspects of infective endocarditis: descriptive review of 90 episodes in a French teaching hospital and risk factors for death. J Infect 2002;45:246-56. https://doi.org/10.1053/jinf.2002.1058
  5. Manne MB, Shrestha NK, Lytle BW, et al. Outcomes after surgical treatment of native and prosthetic valve infective endocarditis. Ann Thorac Surg 2012;93:489-93. https://doi.org/10.1016/j.athoracsur.2011.10.063
  6. Chirouze C, Cabell CH, Fowler VG Jr, et al. Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database. Clin Infect Dis 2004;38: 1323-7. https://doi.org/10.1086/383035
  7. Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ. Risk factors for the development of prosthetic valve endocarditis. Circulation 1985;72:31-7. https://doi.org/10.1161/01.CIR.72.1.31
  8. John MD, Hibberd PL, Karchmer AW, Sleeper LA, Calderwood SB. Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. Clin Infect Dis 1998;26:1302-9. https://doi.org/10.1086/516378

Cited by

  1. Late Postoperative Prosthetic Pulmonary Valve Endocarditis in a 13-Year-Old Girl with Repaired Tetralogy of Fallot vol.42, pp.3, 2013, https://doi.org/10.14503/thij-14-4130
  2. Prosthetic pulmonary valve and conduit endocarditis in congenital heart disease vol.27, pp.4, 2013, https://doi.org/10.1177/0218492319832769